CCL2 and Alzheimer disease: While our study is consistent with these studies, Lee et al. (46) study with more patients and 2 years of follow-up found higher plasma MCP-1 levels in patients with AD compared to patients with MCI and controls (46), and their finding was consistent with another study that included a large cohort of patients with AD (19).